APLT Company Profile and Key Details
Applied Therapeutics, Inc.
APLT Stock Price Chart
Stock Price Today
Applied Therapeutics, Inc. (APLT) stock declined over -0.02%, trading at $0.66 on NASDAQ, down from the previous close of $0.66. The stock opened at $0.64, fluctuating between $0.63 and $0.71 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Company Information
| Employees | 37 |
| Beta | 2.02 |
| Sales or Revenue | $9.99M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Applied Therapeutics, Inc. (NASDAQ: APLT) stock price is $0.66 in the last trading session. During the trading session, APLT stock reached the peak price of $0.71 while $0.63 was the lowest point it dropped to. The percentage change in APLT stock occurred in the recent session was -0.02% while the dollar amount for the price change in APLT stock was -$0.00.
The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Healthcare sector. Applied Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Chids Mahadevan
Senior Vice President of Fin. & Interim Principal Financial Officer
Mr. Steven Ortega
Chief Accounting Officer & Interim Principal Financial Officer
Dr. Shoshana Shendelman Ph.D.
Chair of the Board of Directors, Founder, Pres, Chief Executive Officer & Sec.
Dr. Riccardo Perfetti M.D., Ph.D.
Chief Medical Officer
Mr. Adam Hansard
Chief Commercial Officer
Ms. Catherine Thorpe
Interim Principal Financial Officer & Chief Accounting Officer
APLT's closing price is 8.84% higher than its 52-week low of $0.60 where as its distance from 52-week high of $10.62 is -93.83%.
Number of APLT employees currently stands at 37.
Official Website of APLT is: https://www.appliedtherapeutics.com
APLT could be contacted at phone 212 220 9226 and can also be accessed through its website. APLT operates from 545 Fifth Avenue, New York, NY 10017, United States.
APLT stock volume for the day was 2.75M shares. The average number of APLT shares traded daily for last 3 months was 6.84M.
The market value of APLT currently stands at $76.22M with its latest stock price at $0.66 and 116.36M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com